Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson acquired 32,640 shares of the stock in a transaction on Tuesday, March 25th. The shares were acquired at an average cost of GBX 54 ($0.70) per share, for a total transaction of £17,625.60 ($22,819.26).
Giles Wilson also recently made the following trade(s):
- On Tuesday, March 11th, Giles Wilson bought 269 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 56 ($0.73) per share, with a total value of £150.64 ($195.03).
- On Tuesday, February 11th, Giles Wilson purchased 207 shares of Dr. Martens stock. The stock was bought at an average price of GBX 73 ($0.95) per share, for a total transaction of £151.11 ($195.64).
- On Monday, January 13th, Giles Wilson acquired 222 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 68 ($0.88) per share, with a total value of £150.96 ($195.44).
Dr. Martens Stock Performance
Shares of LON:DOCS traded down GBX 0.15 ($0.00) during trading on Wednesday, reaching GBX 53.60 ($0.69). The company had a trading volume of 373,091 shares, compared to its average volume of 2,799,119. Dr. Martens plc has a fifty-two week low of GBX 49.32 ($0.64) and a fifty-two week high of GBX 99.40 ($1.29). The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The stock’s fifty day moving average price is GBX 65.55 and its 200 day moving average price is GBX 63.70. The firm has a market capitalization of £520.33 million, a price-to-earnings ratio of 7.60, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.
Dr. Martens Cuts Dividend
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Stories
- Five stocks we like better than Dr. Martens
- What is a buyback in stocks? A comprehensive guide for investors
- Palantir Setting Up to Be a Big Winner With New Defense Spending
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Advanced Micro Devices Can Double in Price: Here’s Why
- P/E Ratio Calculation: How to Assess Stocks
- How Disney’s Experiences Segment Can Restore the House of Mouse
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.